< 0 1 0 1 O
18 2 4 2 4 B-upper_bound
or 5 7 5 7 O
> 8 9 8 9 O
79 10 12 10 12 B-lower_bound
years 13 18 13 18 I-lower_bound
of 19 21 19 21 O
age 22 25 22 25 B-age

Ages 0 4 26 30 B-age
18 5 7 31 33 B-lower_bound
- 7 8 33 34 O
79 8 10 34 36 B-upper_bound
years 11 16 37 42 I-upper_bound

Allergy 0 7 43 50 O
to 8 10 51 53 O
5 11 12 54 55 B-allergy_name
- 13 14 56 57 I-allergy_name
aminolevulinic 15 29 58 72 I-allergy_name
acid 30 34 73 77 I-allergy_name
( 35 36 78 79 I-allergy_name
ALA 36 39 79 82 I-allergy_name
) 39 40 82 83 I-allergy_name
or 41 43 84 86 O
any 44 47 87 90 O
component 48 57 91 100 B-allergy_name
of 58 60 101 103 I-allergy_name
the 61 64 104 107 I-allergy_name
vehicle 65 72 108 115 I-allergy_name

Any 0 3 116 119 O
history 4 11 120 127 O
or 12 14 128 130 O
evidence 15 23 131 139 O
of 24 26 140 142 O
severe 27 33 143 149 B-chronic_disease
illness 34 41 150 157 I-chronic_disease
or 42 44 158 160 O
any 45 48 161 164 O
other 49 54 165 170 O
condition 55 64 171 180 O
that 65 69 181 185 O
would 70 75 186 191 O
make 76 80 192 196 O
the 81 84 197 200 O
patient 85 92 201 208 O
, 92 93 208 209 O
in 94 96 210 212 O
the 97 100 213 216 O
opinion 101 108 217 224 O
of 109 111 225 227 O
the 112 115 228 231 O
investigator 116 128 232 244 O
, 128 129 244 245 O
unsuitable 130 140 246 256 O
for 141 144 257 260 O
the 145 148 261 264 O
study 149 154 265 270 O

Clinical 0 8 271 279 O
diagnosis 9 18 280 289 O
of 19 21 290 292 O
papulopustular 22 36 293 307 B-chronic_disease
rosacea 37 44 308 315 I-chronic_disease
based 45 50 316 321 O
on 51 53 322 324 O
physician 54 63 325 334 O
evaluation 64 74 335 345 O

Cosmetic 0 8 346 354 O
procedures 9 19 355 365 O
( 20 21 366 367 O
e.g. 21 25 367 371 O
, 25 26 371 372 O
superficial 27 38 373 384 O
chemical 39 47 385 393 O
peels 48 53 394 399 O
, 53 54 399 400 O
exfoliation 55 66 401 412 O
or 67 69 413 415 O
microdermabrasion 70 87 416 433 O
of 88 90 434 436 O
the 91 94 437 440 O
face 95 99 441 445 O
) 99 100 445 446 O
within 101 107 447 453 O
2 108 109 454 455 B-upper_bound
months 110 116 456 462 I-upper_bound
prior 117 122 463 468 I-upper_bound
to 123 125 469 471 O
Visit 126 131 472 477 O
1 132 133 478 479 O

Eligible 0 8 480 488 O
women 9 14 489 494 B-gender
of 15 17 495 497 O
reproductive 18 30 498 510 O
age 31 34 511 514 B-age
will 35 39 515 519 O
be 40 42 520 522 O
required 43 51 523 531 O
to 52 54 532 534 O
have 55 59 535 539 O
a 60 61 540 541 O
negative 62 70 542 550 B-pregnancy
urine 71 76 551 556 I-pregnancy
pregnancy 77 86 557 566 I-pregnancy
test 87 91 567 571 O
at 92 94 572 574 O
screening 95 104 575 584 O

History 0 7 585 592 O
of 8 10 593 595 O
disorder 11 19 596 604 B-chronic_disease
of 20 22 605 607 I-chronic_disease
porphyrin 23 32 608 617 I-chronic_disease
metabolism 33 43 618 628 I-chronic_disease

History 0 7 629 636 O
of 8 10 637 639 O
failing 11 18 640 647 O
at 19 21 648 650 O
least 22 27 651 656 O
one 28 31 657 660 B-lower_bound
conventional 32 44 661 673 B-treatment
treatment 45 54 674 683 I-treatment
for 55 58 684 687 O
rosacea 59 66 688 695 B-chronic_disease
( 67 68 696 697 O
metronidazole 68 81 697 710 B-treatment
, 81 82 710 711 O
sodium 83 89 712 718 B-treatment
sulfacetamide 90 103 719 732 I-treatment
, 103 104 732 733 O
tetracycline 105 117 734 746 B-treatment
, 117 118 746 747 O
azelaic 119 126 748 755 B-treatment
acid 127 131 756 760 I-treatment
) 131 132 760 761 O
or 133 135 762 764 O
not 136 139 765 768 O
interested 140 150 769 779 O
in 151 153 780 782 O
continuous 154 164 783 793 O
treatment 165 174 794 803 O
with 175 179 804 808 O
these 180 185 809 814 O
agents 186 192 815 821 O

Known 0 5 822 827 O
or 6 8 828 830 O
suspected 9 18 831 840 O
history 19 26 841 848 O
of 27 29 849 851 O
drug 30 34 852 856 O
or 35 37 857 859 O
alcohol 38 45 860 867 O
abuse 46 51 868 873 O
within 52 58 874 880 O
the 59 62 881 884 O
past 63 67 885 889 B-upper_bound
6 68 69 890 891 I-upper_bound
months 70 76 892 898 I-upper_bound
as 77 79 899 901 O
determined 80 90 902 912 O
by 91 93 913 915 O
the 94 97 916 919 O
medical 98 105 920 927 O
record 106 112 928 934 O
or 113 115 935 937 O
patient 116 123 938 945 O
interview 124 133 946 955 O

Only 0 4 956 960 O
patients 5 13 961 969 O
with 14 18 970 974 O
3 19 20 975 976 B-lower_bound
- 20 21 976 977 O
50 21 23 977 979 B-upper_bound
papules 24 31 980 987 B-clinical_variable
and/or 32 38 988 994 I-clinical_variable
pustules 39 47 995 1003 I-clinical_variable
, 47 48 1003 1004 O
and 49 52 1005 1008 O
a 53 54 1009 1010 O
CEA 55 58 1011 1014 B-clinical_variable
total 59 64 1015 1020 I-clinical_variable
score 65 70 1021 1026 I-clinical_variable
â‰¥ 71 72 1027 1028 O
5 73 74 1029 1030 O
, 74 75 1030 1031 O
( 76 77 1032 1033 O
See 77 80 1033 1036 O
Section 81 88 1037 1044 O
4.1.3 89 94 1045 1050 O
) 94 95 1050 1051 O
will 96 100 1052 1056 O
be 101 103 1057 1059 O
enrolled 104 112 1060 1068 O

Participation 0 13 1069 1082 O
in 14 16 1083 1085 O
another 17 24 1086 1093 B-treatment
clinical 25 33 1094 1102 I-treatment
experimental 34 46 1103 1115 I-treatment
therapeutic 47 58 1116 1127 I-treatment
study 59 64 1128 1133 I-treatment
within 65 71 1134 1140 O
30 72 74 1141 1143 B-upper_bound
days 75 79 1144 1148 I-upper_bound
of 80 82 1149 1151 O
screening 83 92 1152 1161 O
visit 93 98 1162 1167 O

Pregnant 0 8 1168 1176 B-pregnancy
females 9 16 1177 1184 B-gender
or 17 19 1185 1187 O
nursing 20 27 1188 1195 O
mothers 28 35 1196 1203 O

Scarring 0 8 1204 1212 O
or 9 11 1213 1215 O
infection 12 21 1216 1225 B-chronic_disease
in 22 24 1226 1228 O
the 25 28 1229 1232 O
area 29 33 1233 1237 O
being 34 39 1238 1243 O
treated 40 47 1244 1251 O

They 0 4 1252 1256 O
will 5 9 1257 1261 O
also 10 14 1262 1266 O
be 15 17 1267 1269 O
required 18 26 1270 1278 O
to 27 29 1279 1281 O
be 30 32 1282 1284 B-contraception_consent
on 33 35 1285 1287 I-contraception_consent
at 36 38 1288 1290 I-contraception_consent
least 39 44 1291 1296 I-contraception_consent
one 45 48 1297 1300 I-contraception_consent
reliable 49 57 1301 1309 I-contraception_consent
form 58 62 1310 1314 I-contraception_consent
of 63 65 1315 1317 I-contraception_consent
effective 66 75 1318 1327 I-contraception_consent
birth 76 81 1328 1333 I-contraception_consent
control 82 89 1334 1341 I-contraception_consent
[ 90 91 1342 1343 O
examples 91 99 1343 1351 O
: 99 100 1351 1352 O
barrier 101 108 1353 1360 B-contraception_consent
method 109 115 1361 1367 I-contraception_consent
( 116 117 1368 1369 I-contraception_consent
condoms 117 124 1369 1376 I-contraception_consent
, 124 125 1376 1377 I-contraception_consent
diaphragm 126 135 1378 1387 I-contraception_consent
) 135 136 1387 1388 I-contraception_consent
, 136 137 1388 1389 O
oral 138 142 1390 1394 B-contraception_consent
, 142 143 1394 1395 O
injectable 144 154 1396 1406 B-contraception_consent
, 154 155 1406 1407 O
implant 156 163 1408 1415 B-contraception_consent
birth 164 169 1416 1421 I-contraception_consent
control 170 177 1422 1429 I-contraception_consent
or 178 180 1430 1432 O
abstinence 181 191 1433 1443 B-contraception_consent
] 191 192 1443 1444 O
during 193 199 1445 1451 O
the 200 203 1452 1455 O
course 204 210 1456 1462 O
of 211 213 1463 1465 O
this 214 218 1466 1470 O
study 219 224 1471 1476 O
and 225 228 1477 1480 O
30 229 231 1481 1483 O
days 232 236 1484 1488 O
following 237 246 1489 1498 O
the 247 250 1499 1502 O
last 251 255 1503 1507 O
treatment 256 265 1508 1517 B-treatment
period 266 272 1518 1524 O

Use 0 3 1525 1528 O
of 4 6 1529 1531 O
laser 7 12 1532 1537 B-treatment
or 13 15 1538 1540 I-treatment
light 16 21 1541 1546 I-treatment
based 22 27 1547 1552 I-treatment
rosacea 28 35 1553 1560 I-treatment
treatments 36 46 1561 1571 I-treatment
( 47 48 1572 1573 O
on 48 50 1573 1575 O
the 51 54 1576 1579 O
face 55 59 1580 1584 O
) 59 60 1584 1585 O
within 61 67 1586 1592 O
1 68 69 1593 1594 B-upper_bound
month 70 75 1595 1600 I-upper_bound
prior 76 81 1601 1606 I-upper_bound
to 82 84 1607 1609 O
Visit 85 90 1610 1615 O
1 91 92 1616 1617 O

Use 0 3 1618 1621 O
of 4 6 1622 1624 O
systemic 7 15 1625 1633 B-treatment
antibiotics 16 27 1634 1645 I-treatment
within 28 34 1646 1652 O
1 35 36 1653 1654 B-upper_bound
month 37 42 1655 1660 I-upper_bound
prior 43 48 1661 1666 I-upper_bound
to 49 51 1667 1669 O
Visit 52 57 1670 1675 O
1 58 59 1676 1677 O

Use 0 3 1678 1681 O
of 4 6 1682 1684 O
systemic 7 15 1685 1693 B-treatment
corticosteroids 16 31 1694 1709 I-treatment
3 32 33 1710 1711 B-upper_bound
months 34 40 1712 1718 I-upper_bound
prior 41 46 1719 1724 I-upper_bound
to 47 49 1725 1727 O
Visit 50 55 1728 1733 O
1 56 57 1734 1735 O

Use 0 3 1736 1739 O
of 4 6 1740 1742 O
systemic 7 15 1743 1751 B-treatment
retinoids 16 25 1752 1761 I-treatment
, 25 26 1761 1762 O
including 27 36 1763 1772 O
isotretinoin 37 49 1773 1785 B-treatment
, 49 50 1785 1786 O
within 51 57 1787 1793 O
6 58 59 1794 1795 B-upper_bound
months 60 66 1796 1802 I-upper_bound
prior 67 72 1803 1808 I-upper_bound
to 73 75 1809 1811 O
Visit 76 81 1812 1817 O
1 82 83 1818 1819 O

Use 0 3 1820 1823 O
of 4 6 1824 1826 O
topical 7 14 1827 1834 B-treatment
acne 15 19 1835 1839 I-treatment
or 20 22 1840 1842 O
rosacea 23 30 1843 1850 B-treatment
treatments 31 41 1851 1861 I-treatment
( 42 43 1862 1863 O
on 43 45 1863 1865 O
the 46 49 1866 1869 O
face 50 54 1870 1874 O
) 54 55 1874 1875 O
within 56 62 1876 1882 O
2 63 64 1883 1884 B-upper_bound
weeks 65 70 1885 1890 I-upper_bound
prior 71 76 1891 1896 I-upper_bound
to 77 79 1897 1899 O
Visit 80 85 1900 1905 O
1 86 87 1906 1907 O

Use 0 3 1908 1911 O
of 4 6 1912 1914 O
topical 7 14 1915 1922 B-treatment
corticosteroids 15 30 1923 1938 I-treatment
( 31 32 1939 1940 O
on 32 34 1940 1942 O
the 35 38 1943 1946 O
face 39 43 1947 1951 O
) 43 44 1951 1952 O
1 45 46 1953 1954 B-upper_bound
month 47 52 1955 1960 I-upper_bound
prior 53 58 1961 1966 I-upper_bound
to 59 61 1967 1969 O
Visit 62 67 1970 1975 O
1 68 69 1976 1977 O

Use 0 3 1978 1981 O
of 4 6 1982 1984 O
topical 7 14 1985 1992 B-treatment
retinoids 15 24 1993 2002 I-treatment
( 25 26 2003 2004 O
on 26 28 2004 2006 O
the 29 32 2007 2010 O
face 33 37 2011 2015 O
) 37 38 2015 2016 O
within 39 45 2017 2023 O
1 46 47 2024 2025 B-upper_bound
month 48 53 2026 2031 I-upper_bound
prior 54 59 2032 2037 I-upper_bound
to 60 62 2038 2040 O
Visit 63 68 2041 2046 O
1 69 70 2047 2048 O

